Health & beauty
Omnio
Omnio
A plasminogen-based treatment for chronic wounds such as diabetic foot ulcers.
Umeå, Sweden. Led by CEO Felipe Velasquez.
Announced a 2.9 million euro round from existing investors on 2 October 2026.
Written by our editors from public sources, linked in our story. Not a paid placement. Founders can request a correction.